Literature DB >> 11894977

The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males.

M Zitzmann1, M Brune, B Kornmann, J Gromoll, R Junker, E Nieschlag.   

Abstract

OBJECTIVE: Bone metabolism and bone density (BD) are influenced by sex hormones. Testosterone (T) action is exerted through the androgen receptor (AR). We investigated the potential impact of the CAG repeat (CAGR) polymorphism within the AR gene on BD and bone metabolism in healthy younger males. PATIENTS AND MEASUREMENTS: The number of CAGRs in 110 healthy men aged 20-50 years was determined by sequence analysis. We assessed BD by the radiation-free method of quantitative ultrasound (QUS) of the phalanges. Serum levels of bone-specific alkaline phosphatase (BAP) and urine secretion of free deoxypyridinoline (DPD, corrected for creatinine), serum levels of sex hormones, body fat content and lifestyle factors were determined.
RESULTS: In stepwise multiple regression models controlling for age, body fat content and lifestyle factors, the number of CAGRs was an independent negative predictor of BD (partial r = - 0.286, P = 0.001), whereas it was positively associated with markers of bone turnover (for BAP: partial r = 0.32, P= 0.001; for DPD: partial r = 0-241, P = 0.013). Levels of free T and oestradiol showed an independent and positive association with BD; age contributed significantly to lower BD. Age and free T were negatively associated with markers of bone turnover, whereas oestradiol showed a positive correlation with BAP and DPD. ANOVA in groups according to age and the CAGR length suggested an increased age-dependent bone loss in subjects with a CAGR length of 22-31 compared with 14-21 CAGRs (overall P < 0.01).
CONCLUSIONS: A high number of CAG repeats within the androgen receptor gene attenuates testosterone effects on bone density and bone metabolism. This seems to be associated with accelerated age-dependent bone loss.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11894977     DOI: 10.1046/j.1365-2265.2001.01391.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  15 in total

1.  Association of polymorphisms of the androgen receptor and klotho genes with bone mineral density in Japanese women.

Authors:  Yoshiji Yamada; Fujiko Ando; Naoakira Niino; Hiroshi Shimokata
Journal:  J Mol Med (Berl)       Date:  2004-11-04       Impact factor: 4.599

2.  Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism.

Authors:  G Tirabassi; N delli Muti; A Gioia; A Biagioli; A Lenzi; G Balercia
Journal:  J Endocrinol Invest       Date:  2014-01-24       Impact factor: 4.256

Review 3.  The genetics of bone loss: challenges and prospects.

Authors:  Braxton D Mitchell; Laura M Yerges-Armstrong
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

4.  Androgen receptor CAG repeat polymorphism and hypothalamic-pituitary-gonadal function in Filipino young adult males.

Authors:  Calen P Ryan; Thomas W McDade; Lee T Gettler; Dan T A Eisenberg; Margarita Rzhetskaya; M Geoffey Hayes; Christopher W Kuzawa
Journal:  Am J Hum Biol       Date:  2016-07-15       Impact factor: 1.937

5.  The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men.

Authors:  Ville-Valtteri Välimäki; Kirsi Piippo; Stiina Välimäki; Eliisa Löyttyniemi; Kimmo Kontula; Matti J Välimäki
Journal:  Osteoporos Int       Date:  2005-04-13       Impact factor: 4.507

6.  Androgen receptor CAG repeat size is associated with stress fracture risk: a pilot study.

Authors:  Ran Yanovich; Roni Milgrom; Eitan Friedman; Daniel S Moran
Journal:  Clin Orthop Relat Res       Date:  2011-02-15       Impact factor: 4.176

7.  Bone mass and the CAG and GGN androgen receptor polymorphisms in young men.

Authors:  Amelia Guadalupe-Grau; Francisco Germán Rodríguez-González; Jesús Gustavo Ponce-González; Cecilia Dorado; Hugo Olmedillas; Teresa Fuentes; Jorge Pérez-Gómez; Joaquín Sanchís-Moysi; Bonifacio Nicolás Díaz-Chico; José A L Calbet
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

8.  Salivary testosterone and a trinucleotide (CAG) length polymorphism in the androgen receptor gene predict amygdala reactivity in men.

Authors:  Stephen B Manuck; Anna L Marsland; Janine D Flory; Adam Gorka; Robert E Ferrell; Ahmad R Hariri
Journal:  Psychoneuroendocrinology       Date:  2010-01       Impact factor: 4.905

Review 9.  Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials.

Authors:  Landon W Trost; John P Mulhall
Journal:  J Sex Med       Date:  2016-05-18       Impact factor: 3.802

Review 10.  Testosterone replacement therapy in male hypogonadism.

Authors:  M Byrne; E Nieschlag
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.